Contact

Click here for a confidential contact or call:

1-212-350-2764

COVID-19

This archive displays posts tagged as relevant to the COVID-19/Coronavirus pandemic. You may also be interested in the following pages:

Page 6 of 6

Whistleblower Protection Caucus Co-Chairs Urge Barr to Establish COVID-19 FCA Task Force

Posted  03/27/20
Whistleblower Reward
Efforts to combat the COVID-19 pandemic in the United States will require potentially trillions of taxpayer dollars.  Given the amount of money involved, and the speed at which the crisis is progressing, Whistleblower Protection Caucus Co-Chairs Congresswomen Jackie Speier (CA-14) and Kathleen M. Rice (NY-4) have sent a letter to Attorney General Barr urging him to establish a nationwide COVID-19 fraud prevention...

Loosening the Rules on Telehealth to Fight Coronavirus May Also Result in New Medicare Fraud Schemes

Posted  03/27/20
doctor-on-phone
In response to the coronavirus pandemic, the U.S. government is loosening rules on telehealth to make it easier—and safer—for patients to speak to their healthcare providers.  These steps are an important, and necessary, step to curtail the spread of the virus and to facilitate the treatment of infected patients.  But it may also open the door to new telehealth fraud schemes by unscrupulous individuals and...

The COVID-19 Crisis, Whistleblowers, and the Constantine Cannon Whistleblower Team

Posted  03/19/20
Soapy hands under running water faucet
As Constantine Cannon announced earlier this week, in response to the coronavirus (COVID-19) crisis, we have implemented contingency plans to work remotely.  While our work locations have changed, we remain dedicated to our whistleblower clients, and our team continues to provide whistleblowers with support and legal guidance. With offices in New York, D.C., San Francisco, and London, the Constantine Cannon...

As COVID-19 Spreads, So Does Consumer Fraud

Posted  03/13/20
Coronavirus Disease 2019 Graphic
“There currently are no vaccines, pills, potions, lotions, lozenges or other prescription or over-the-counter products available to treat or cure coronavirus disease 2019 (COVID-19).” This was the firm reminder sent to seven companies this week via FDA-FTC warning letters. The businesses were told to cease unproven efficacy claims in the marketing of their products, and were given 48 hours to respond to the...
1 4 5 6

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: